When the FDA took Novo Nordisk and Eli Lilly’s GLP-1 medications off of the drug shortage list, the move should have been a ...

As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

Serena Williams opens up about her weight loss struggles and the use of GLP-1 medications, highlighting issues of access and ...

The condition MASH (Metabolic Dysfunction-Associated Steatohepatitis) is common and serious.

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...

Managing specialty and cancer drugs, as well as the GLP-1 therapies, tops the list of priorities this year and next, ...

Amongst the horde of huge-name stars who've admitted to taking these types of medication in a bid to help shed a few pounds ...

A significant issue is under enrollment of women in randomized trials, meaning the percentage of women enrolled isn’t in line ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...